Diagnosis and Management of Immunodeficiency in Adults

To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.

Step Status
Video/Document(s)
Posttest
Evaluation
Starts On: 9/27/2019: 12:00 AM
Ends On: 6/30/2020: 12:00 AM
Session Type: Internet Activity Enduring Material
Credits: 0.75
Description:

Faculty

Aaron M. Ver Heul, MD, PhD
Instructor, Medicine
Division of Allergy and Immunology
Disclosures
Ownership Investment: Biogen Idec
Ownership Investment: Merck & Company, Inc.

Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Clinical Allergy for the Practicing Physician, August 9-10, 2019, which was supported in part by CSL Behring, Genentech, Mylan Inc., Lincoln Diagnostics Inc., and Stallergenes-Greer.

Planning Committee

Tiffany Dy, MD, Assistant Professor of Medicine (Course Chair)
Financial Relationships: Speaker has nothing to disclose.

Eli N. Deal, PharmD, FCCP, BCPS (Pharmacist Planner)
Financial Relationships: Speaker has nothing to disclose.

Kaci B. Hale, FNP, BCPS (Nurse Planner)
Financial Relationships: Speaker has nothing to disclose.

Andrew L. Kau, MD, PhD, Assistant Professor of Medicine (Course Co-Chair)
Financial Relationships: Ownership Investment: Gilead Scineces, Viosera Therapeutics

Jennifer Monroy, MD, Assistant Professor of Medicine (Course Co-Chair)
Financial Relationships: Speaker has nothing to disclose.

Jeffrey R. Stokes, MD Professor of Pediatrics (Course Co-Chair)
Financial Relationships: Speaker has nothing to disclose.

Objectives: The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
  • Define the different types of immunoglobulin replacement therapy available today
  • Define the mechanisms of action of immunoglobulin replacement therapy
  • Define indications for immunoglobulin replacement therapy and review guidelines in its use
  • Review common logistical issues with prescribing immunoglobulin replacement therapy
  • Define adverse effects associated with immunoglobulin replacement therapy
Additional Information:
Target Audience: This course is designed for allergists, immunologists, pulmonologists, primary care and family practice physicians, otolaryngologists, pediatricians, internists, dermatologists, nurse practitioners, nurses, physician assistants and all healthcare professionals who care for patients with allergic and immunologic illnesses.

Publication Date: September 27, 2019
Expiration Date: June 30, 2020
Accreditation Information:
wustlcme
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
References:
  • von Behring EA, Kitasato S. Über das zustandekommen der diphtherie-immunität und der tetanus-immunität beitieren. Dtsch Med Wochenschr 1890;16:1113–4.
  • Roux E, Martin L, Chaillou A (1894). Trois cent cas de diphthérie traité par le serum antidiphthérique. Annales de l'Institut Pasteur 8:640-661.
  • Karelitz S. Prophylaxis against measles with the globulin fraction of immune adult serum. Am J Dis Child 1938;55:768–75
  • Tiselius A, Kabat EA. Electrophoresis of immune serum. Science 1938;87:416–7.
  • Cohn EJ, Luetscher JA Jr, Oncley JL, et al. Preparation and properties of serum and plasma proteins. J Am Chem Soc 1940;62:3396–400.
  • Eibl, M. M. (2008). History of Immunoglobulin Replacement. Immunology and Allergy Clinics of North America, 28(4), 737–764.
Disclosure Information: It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.

Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.

These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Categories: Allergy, Pediatric, Pulmonology


Powered By AI 4.5